RxDoctor Payments Data

Victoria Wheaton Young

Family · El Centro, CANPI 1427311323

Payments from drug & device makers

$4,547in general payments, 2019–2025

Across 127 payments — averaging $35.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$572
  • Amgen$405
  • GSK$271
  • Bayer$264
  • Merck$219
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,547 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide12$20,007
ProliaDenosumab11$18,236
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,812
JanuviaSitagliptin Phosphate14$13,465
EliquisApixaban13$10,701
FarxigaDapagliflozin Propanediol13$8,884
XareltoRivaroxaban11$7,494
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$5,500
Atorvastatin Calcium112$1,493
Albuterol Sulfate HfaAlbuterol Sulfate31$1,206
Tamsulosin Hcl36$938
Metoprolol Succinate41$803
Amlodipine Besylate82$709
Levothyroxine Sodium51$707
Omeprazole54$596

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$189$20,00712 claims
AmgenProlia$405$18,23611 claims
GSKTrelegy Ellipta$271$16,81216 claims
MerckJanuvia$219$13,46514 claims
PfizerEliquis$17$10,70113 claims
AstraZenecaFarxiga$1,237$8,88413 claims
Johnson & JohnsonXarelto$21$7,49411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in El Centro

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →